Table 1 New patients starting their first renal replacement therapy (dialysis or with a pre-emptive kidney transplant) in the PACA region from 2014 to 2015

All new patients starting RRT

664

739

737

762

808

837

832

912

889

913

951

1011

Pre-emptive transplant, n (%)

7 (1.1)

5 (0.7)

6 (0.8)

15 (2.0)

24 (3.0)

11 (1.3)

21 (2.5)

22 (2.4)

21 (2.4)

35 (3.8)

37 (3.9)

29 (2.9)

Initial dialysis, n (%)

657 (98.9)

734 (99.3)

731 (99.2)

747 (98.0)

784 (97.0)

826 (98.7)

811 (97.5)

890 (97.6)

868 (97.6)

878 (96.2)

914 (96.1)

982 (97.1)

 Age Mean ± SD^b

68.5 ± 15.7

67.9 ± 15.5

68.4 ± 15.5

68.1 ± 15.8

70.0 ± 14.7

68.3 ± 16.8

70.6 ± 15.1

70.7 ± 15.3

71.1 ± 15.4

70.3 ± 14.6

70.9 ± 14.8

70.1 ± 16.5

 <  20 years, n (%)

9 (1.4)

4 (0.5)

7 (1.0)

9 (1.2)

7 (0.9)

15 (1.8)

10 (1.2)

10 (1.1)

6 (0.7)

6 (0.7)

2 (0.2)

14 (1.4)

 ≥ 80 years, n (%)

160 (24.4)

154 (21.0)

167 (22.8)

172 (23.0)

214 (27.3)

241 (29.2)

246 (30.3)

278 (31.2)

287 (33.1)

255 (29.0)

295 (32.3)

315 (32.1)

Gender: Male, n (%)

416 (63.3)

448 (61.0)

460 (62.9)

484 (64.8)

474 (60.5)

554 (67.1)

527 (65.0)

566 (63.7)

587 (67.6)

586 (66.7)

589 (64.4)

644 (65.6)

Residing outside the region PACA, n (%)

15 (2.3)

20 (2.7)

15 (2.1)

13 (1.7)

18 (2.3)

26 (3.1)

16 (2.0)

22 (2.5)

28 (3.2)

13 (1.5)

10 (1.1)

15 (1.5)

 None

151 (23.0)

167 (22.8)

178 (24.4)

203 (27.2)

190 (24.2)

244 (29.5)

200 (24.7)

191 (21.5)

206 (23.7)

202 (23.0)

171 (18.7)

229 (23.3)

 Mean number ± SD^a

2.2 ± 1.3

2.1 ± 1.3

2.2 ± 1.4

2.1 ± 1.3

2.1 ± 1.2

2.3 ± 1.4

2.2 ± 1.3

2.5 ± 1.4

2.4 ± 1.4

2.5 ± 1.6

2.4 ± 1.5

2.4 ± 1.6

 Diabetes, n (%)

212

253

252

243

302

290

306

356

345

368

389

400

 MD = 4.4% (10.6–0.2)

(37.2)

(39.8)

(35.9)

(36.1)

(40.3)

(35.3)

(38.1)

(40.4)

(40.0)

(42.2)

(42.9)

(41.0)

 At least one CVD^d

307

319

371

335

388

418

440

525

497

490

546

546

 MD = 5.3% (14.3–1.1)

(54.5)

(50.6)

(52.9)

(50.5)

(52.2)

(51.7)

(56.0)

(60.1)

(57.9)

(56.5)

(60.5)

(56.9)

 Cancer

37

60

68

53

65

59

77

86

106

102

100

112

 MD = 4.9% (10.9–0.6)

(6.6)

(9.5)

(9.7)

(8.0)

(8.7)

(7.4)

(9.9)

(9.9)

(12.5)

(11.8)

(11.1)

(11.7)

BMI^e, n (%)

MD = 22.6% (57.4–2.7)

 Underweight (< 18.5)

38 (7.9)

39 (7.2)

29 (5.6)

37 (7.3)

44 (7.7)

39 (5.9)

46 (6.7)

58 (7.4)

41 (5.4)

37 (4.6)

46 (5.5)

38 (4.3)

 Normal (18.5–24.9)

239 (49.7)

273 (50.3)

231 (44.6)

259 (51.2)

272 (47.5)

315 (47.7)

336 (48.8)

363 (46.1)

321 (41.9)

344 (42.4)

330 (39.1)

366 (41.7)

 Overweight (25.0–29.9)

149 (31.0)

155 (28.5)

175 (33.8)

151 (29.8)

177 (30.9)

203 (30.7)

182 (26.5)

230 (29.2)

257 (33.6)

256 (31.5)

259 (30.7)

297 (33.8)

 Obese (≥ 30)

55 (11.4)

76 (14.0)

83 (16.0)

59 (11.7)

80 (14.0)

104 (15.7)

124 (18.0)

137 (17.4)

147 (19.2)

175 (21.6)

209 (24.8)

177 (20.2)

DP^f

49 (7.5)

58 (7.9)

49 (6.7)

46 (6.2)

32 (4.1)

50 (6.1)

49 (6.0)

59 (6.6)

65 (7.5)

71 (8.1)

71 (7.8)

81 (8.2)

HD^g

608 (92.5)

676 (92.1)

682 (93.3)

701 (93.8)

752 (95.9)

776 (93.9)

762 (94.0)

831 (93.4)

803 (92.5)

807 (91.9)

843 (92.2)

901 (91.8)

 In-center HD

543 (89.3)

608 (89.9)

622 (91.2)

622 (88.7)

676 (89.9)

691 (89.0)

694 (91.1)

729 (87.7)

745 (92.8)

729 (90.3)

777 (92.2)

816 (90.6)

 HD in medical satellite unit

–

1 (0.1)

4 (0.6)

10 (1.4)

11 (1.5)

15 (1.9)

18 (2.4)

32 (3.9)

25 (3.1)

38 (4.7)

38 (4.5)

47 (50.2)

 HD in self-care unit

54 (8.9)

54 (8.0)

40 (5.9)

51 (7.3)

43 (5.7)

41 (5.3)

33 (4.3)

33 (4.0)

13 (1.6)

22 (2.7)

22 (2.6)

28 (3.1)

 HD at home

11 (1.8)

13 (1.9)

15 (2.2)

18 (2.6)

22 (2.9)

29 (3.7)

17 (2.2)

37 (4.5)

20 (2.5)

18 (2.2)

6 (0.7)

10 (1.1)